Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L31 pseudogene 28 (RPL31P28) is a processed pseudogene of the ribosomal protein L31 gene family in the human genome[2][4]. Unlike functional ribosomal protein genes, pseudogenes like RPL31P28 are generally non-coding and do not produce functional proteins. They are derived from ancestral ribosomal protein genes but have lost the ability to encode proteins due to mutations or truncations[2][4]. There is no evidence that RPL31P28 encodes a product or has specific biological or disease roles. As a pseudogene, it is not considered a therapeutic target, and no drugs, mechanisms of action, or biomarker relevance are associated with this entity. RPL31P28 is distinguished from its functional counterpart RPL31, which encodes a ribosomal protein of the large 60S subunit involved in protein synthesis[1]. Pseudogenes may be transcribed in some cases but do not translate into functional proteins, and their biological roles (if any) are not well characterized. RPL31P28 appears as an annotated entity in human gene databases (NCBI Gene, Ensembl) but is not a target for therapeutics, nor is it implicated in disease according to available data[2][4]. No evidence was found of associative disease links, biological functions, or utility as a biomarker. There are no known interacting drugs or specific safety/therapeutic concerns. If you require information about the functional ribosomal protein L31 (RPL31) gene instead of the pseudogene, please clarify.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L31 pseudogene 28 (RPL31P28).